Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Rolf Issels"'
Autor:
Paraskevi Danai Veltsista, Eva Oberacker, Adela Ademaj, Stefanie Corradini, Franziska Eckert, Anne Flörcken, David Kaul, Lars H. Lindner, Rolf Issels, Oliver J. Ott, Daniel Pink, Vlatko Potkrajcic, Peter Reichardt, Siyer Roohani, Mateusz Jacek Spalek, Oliver Riesterer, Daniel Zips, Pirus Ghadjar
Publikováno v:
International Journal of Hyperthermia, Vol 40, Iss 1 (2023)
AbstractBackground The therapy of high-risk soft tissue sarcomas (STS) remains an interdisciplinary challenge. Regional hyperthermia (RHT) sparked interest as it has been shown to improve overall survival when added to perioperative chemotherapy (CTX
Externí odkaz:
https://doaj.org/article/7dc1791f2ac14144a2dcb1a1aa18630f
Autor:
Veit Bücklein, Christina Limmroth, Eric Kampmann, Gesa Schuebbe, Rolf Issels, Falk Roeder, Martin Angele, Hans Roland Dürr, Thomas Knösel, Sultan Abdel-Rahman, Dorit Di Gioia, Lars H. Lindner
Publikováno v:
Sarcoma, Vol 2020 (2020)
Patients with localized relapse of soft-tissue sarcoma (STS) after anthracycline-based chemotherapy have a dismal prognosis, particularly when surgery is not possible. To facilitate resection and improve long-term tumor control, we applied an intensi
Externí odkaz:
https://doaj.org/article/8fa5347fd1844408b407e1abc0a34195
Autor:
Rolf Issels
Publikováno v:
InFo Hämatologie + Onkologie. 23:3-5
Autor:
Martin F, Orth, Veit Leonhard, Buecklein, Eric, Kampmann, Marion, Subklewe, Elfriede, Noessner, Florencia, Cidre-Aranaz, Laura, Romero-Pérez, Fabienne Sophie, Wehweck, Lars, Lindner, Rolf, Issels, Thomas, Kirchner, Annelore, Altendorf-Hofmann, Thomas G P, Grünewald, Thomas, Knösel
Publikováno v:
Cancer immunology, immunotherapy : CII. 69(7)
Soft tissue sarcomas (STSs) are heterogeneous cancers associated with poor prognosis due to high rates of local recurrence and metastasis. The programmed death receptor ligand 1 (PD-L1) is expressed in several cancers. PD-L1 interacts with its recept
Autor:
Piotr Rutkowski, Enrique De Alava, Javier Martin-Broto, Hans Gelderblom, ANGELO DEI TOS, Jean-Yves Blay, Leo Kager, Silvia Stacchiotti, Alessandro Gronchi, Rolf Issels
Publikováno v:
Annals of Oncology. 23:vii49-vii55
Autor:
Piotr Rutkowski, Enrique De Alava, Hans Gelderblom, ANGELO DEI TOS, Jean-Yves Blay, Leo Kager, Silvia Stacchiotti, Alessandro Gronchi, Rolf Issels
Publikováno v:
Annals of Oncology. 23:vii92-vii99
Autor:
Piotr Rutkowski, Paola Collini, Paolo Giovanni Casali, Robert G. Maki, ANGELO DEI TOS, Jean-Yves Blay, Alessandro Gronchi, Rolf Issels
Publikováno v:
Annals of Oncology. 19:ii35-ii38
Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up P. G. Casali, L. Jost, P. Reichardt, M. Schlemmer & J.-Y. Blay On behalf of the ESMO Guidelines Working Group* Department of Cancer Medicine, Istitu
Autor:
Tumorzentrum München, Rolf Issels
Das Manual zu den Knochentumoren und Weichteilsarkome bietet einen Überblick über das Vorgehen bei diesen Patientengruppen. Das Buch wurde interdisziplinär erarbeitet und bietet Information zur Diagnostik und Therapie an, sowohl für die Primär-
Autor:
Piotr Rutkowski, Enrique De Alava, Javier Martin-Broto, Hans Gelderblom, ANGELO DEI TOS, Leo Kager, Silvia Stacchiotti, Alessandro Gronchi, Rolf Issels
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 23
Combination of hyperthermia and bortezomib results in additive killing in mantle cell lymphoma cells
Autor:
Valeria Milani, Monika Lorenz, Marc Weinkauf, Malte Rieken, Alessandro Pastore, Martin Dreyling, Rolf Issels
Publikováno v:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 25(4)
The proteasome inhibitor bortezomib exhibits antitumor activity in many malignancies including mantle cell lymphoma (MCL). Unfortunately, many patients fail to respond to treatment or become refractory. Hyperthermia is an effective chemosensitizer th